您的位置: 首页 > 农业专利 > 详情页

Yi Seed BTK kinase inhibition Elixirs Knot crystalline form is Ji Qi System Prepare method
专利权人:
江蘇恒瑞醫藥股份有限公司;JIANGSU HENGRUI MEDICINE CO., LTD.;江苏恒瑞医药股份有限公司
发明人:
WU, Guaili,武乖利,QIU, Zhenjun,邱振均,LU, Xi,芦熙,蘆熙,LU, Yun,卢韵,盧韵
申请号:
MOJ003606
公开号:
MOJ003606B
申请日:
2019.02.25
申请国别(地区):
MO
年份:
2019
代理人:
摘要:
This Hair is bright to be related to Yi Seed BTK kinase inhibition Elixirs Knot crystalline form Ji Qi System Prepare method. Ju Body , this Hair it is bright be related to (R) -4- amino -1- (1- (butyl- 2- alkynes acyl group) pyrrolidin-3-yl) -3- (4- (2,6- difluoro phenoxy group) phenyl) -1,Bis- Hydrogen -7H- pyrrolo- of 6- [2,The I Xing Knot crystalline substance of 3-d] Da piperazine -7- ketone (formula (I) compound) is Ji Qi System Prepare method. The I Xing Knot crystalline substance qualitative , And of the tool qualitative Heization Learn Steady of the good crystal form Steady of Prepare and Suo of formula (I) compound obtained by this Hair is bright are stayed Yong the low Disabled of the brilliant molten Elixirs low toxicity of Knot, can preferably Yong Yu Pro control Treatment.本發明涉及一種BTK激酶抑制劑的結晶形式及其製備方法。具體地,本發明涉及(R)‑4‑氨基‑1‑(1‑(丁‑2‑炔酰基)吡咯烷‑3‑基)‑3‑(4‑(2,6‑二氟苯氧基)苯基)‑1,6‑二氫‑7H‑吡咯并[2,3‑d]噠嗪‑7‑酮(式(I)化合物)的I型結晶及其製備方法。本發明所得到式(I)化合物的I型結晶具備良好的晶型穩定性和化學穩定性,並且所用結晶溶劑低毒低殘留,可更好地用於臨床治療。
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充